Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Public ClinicalTrials.gov record NCT01331109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, 52-Week Extension Study to Evaluate the Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety and efficacy of milnacipran in pediatric patients aged 13 to 17 years with primary fibromyalgia.
Study identification
- NCT ID
- NCT01331109
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2011
- Primary completion
- Jul 31, 2012
- Completion
- Jul 31, 2012
- Last update posted
- Sep 29, 2013
2011 – 2012
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 040 | Birmingham | Alabama | 35205 | — |
| Forest Investigative Site 033 | Bullhead City | Arizona | 86442 | — |
| Forest Investigative Site 012 | Fresno | California | 93710 | — |
| Forest Investigative Site 045 | Fresno | California | 93720 | — |
| Forest Investigative Site 051 | Fresno | California | 93721 | — |
| Forest Investigative Site 035 | Orange | California | 92868 | — |
| Forest Investigative Site 053 | Orange | California | 92868 | — |
| Forest Investigative Site 050 | Sacramento | California | 95825 | — |
| Forest Investigative Site 034 | Colorado Springs | Colorado | 80907 | — |
| Forest Investigative Site 014 | Spring Hill | Florida | 34609 | — |
| Forest Investigative Site 055 | West Palm Beach | Florida | 33409 | — |
| Forest Investigative Site 058 | Blue Ridge | Georgia | 30513 | — |
| Forest Investigative Site 010 | Peoria | Illinois | 61614 | — |
| Forest Investigative Site 017 | Louisville | Kentucky | 40202 | — |
| Forest Investigative Site 009 | Ann Arbor | Michigan | 48104 | — |
| Forest Investigative Site 024 | Rochester Hills | Michigan | 48307 | — |
| Forest Investigative Site 036 | Stevensville | Michigan | 49127 | — |
| Forest Investigative Site 049 | Whitehouse Station | New Jersey | 08889 | — |
| Forest Investigative Site 018 | Albuquerque | New Mexico | 87109 | — |
| Forest Investigative Site 062 | Raleigh | North Carolina | 27612 | — |
| Forest Investigative Site 052 | Winston-Salem | North Carolina | 27103 | — |
| Forest Investigative Site 016 | Cincinnati | Ohio | 45219 | — |
| Forest Investigative Site 015 | Dayton | Ohio | 45432 | — |
| Forest Investigative Site 046 | Greer | South Carolina | 29650 | — |
| Forest Investigative Site 023 | Austin | Texas | 78732 | — |
| Forest Investigative Site 003 | San Antonio | Texas | 78215 | — |
| Forest Investigative Site 042 | San Antonio | Texas | 78258 | — |
| Forest Investigative Site 025 | Clinton | Utah | 84015 | — |
| Forest Investigative Site 013 | Salt Lake City | Utah | 84102 | — |
| Forest Investigative Site 063 | Seattle | Washington | 98104 | — |
| Forest Investigative Site 004 | Racine | Wisconsin | 53406 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01331109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01331109 live on ClinicalTrials.gov.